Search results
New postpartum depression drugs are here. Diagnosis, treatment hurdles still stand in the way.
BioPharma Dive via Yahoo Finance· 1 month agoThe first medicine approved for PPD, Sage’s Zulresso, never gained traction. The company is in the...
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive via Yahoo Finance· 2 weeks agoDive Brief: Biogen has seen “encouraging early trends” in the launch of its postpartum depression...
Sage Therapeutics (SAGE) Plunges 46% in a Month: Here's Why
Zacks via Yahoo Finance· 8 months agoThe plunge in Sage's (SAGE) shares comes after the FDA declined to approve Zurzuvae in major...
FDA Approves Fast-Acting Pill for Postpartum Depression
Health via Yahoo News· 1 year agoThe FDA has just approved zuranolone, a new treatment for postpartum depression and major depressive...
Zuranolone, a breakthrough postpartum depression treatment, was just approved by the FDA. The...
Fortune via Yahoo Finance· 9 months agoThe U.S. Food and Drug Administration on Friday approved the first pill designed specifically to...
Postpartum Depression Treatment
Verywell Health via Yahoo News· 2 months agoHelp With Symptoms of Clinical depression Following Delivery Medically reviewed by Renita White, MD Postpartum depression (PPD) refers to depression that...
How These Biotech Players Could Help Treat Covid-Fueled Depression
Investor's Business Daily· 2 years agoThe "brain health pandemic" since Covid struck exposed a glaring void: Current depression treatments...
This is how much the new PPD pill will cost
Motherly via Yahoo News· 6 months agoWhen the news of the Food and Drug Administration’s (FDA) approval of Zurzuvae (zuranolone), the first oral treatment for postpartum depression (PPD) was...
Sage offers details on launch of new postpartum depression pill
BioPharma Dive via Yahoo Finance· 3 months agoThe company and partner Biogen say signs from payers and doctors suggest the launch of Zurzuvae, the...
FDA approves first postpartum depression pill
Popular Science via Yahoo News· 9 months agoPostpartum depression is a leading cause of maternal mortality. On August 4, the United States Food and Drug Administration (FDA) approved zuranolone to...
